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Abstract
Background: Trichohepatoenteric syndrome (THE-S) or phenotypic diarrhoea of infancy is a rare autosomal
recessive disorder characterised by severe infantile diarrhoea, facial dysmorphism, immunodeficiency and woolly
hair. It was first described in 1982 in two infants with intractable diarrhoea, liver cirrhosis and abnormal hair
structure on microscopy. We report on two siblings from a consanguineous family of Somali descent who, despite
extensive clinical investigation, remained undiagnosed until their demise. The index patient died of fulminant
cytomegalovirus pneumonitis at 3 months of age.
Methods: Whole exome sequencing (WES) was performed on a premortem DNA sample from the index case.
Variants in a homozygous recessive state or compound heterozygous state were prioritized as potential candidate
variants using TAPER™. Sanger sequencing was done to genotype the parents, unaffected sibling and a deceased
sibling for the variant of interest.
Results: Exome sequencing identified a novel homozygous mutation (c.4507C > T, rs200067423) in TTC37
which was confirmed by Sanger sequencing in the index case. The identification of this mutation led to the
diagnosis of THE-S in the proband and the same homozygous variant was confirmed in a male sibling who
died 4 years earlier with severe chronic diarrhoea of infancy. The unaffected parents and sister were
heterozygous for the identified variant.
Conclusions: WES permitted definitive genetic diagnosis despite an atypical presentation in the index case
and suggests that severe infection, likely secondary to immunodeficiency, may be a presenting feature. In
addition definitive molecular diagnosis allows for genetic counseling and future prenatal diagnosis, and
demonstrates the value of WES for post-mortem diagnosis of disorders with a non-specific clinical
presentation in which a Mendelian cause is suspected.
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Background
Trichohepatoenteric syndrome (THE-S) is a rare auto-
somal recessive disorder characterised by severe infantile
diarrhoea, intrauterine growth retardation (IUGR), hair
abnormalities (mainly trichorrhexis nodosa), skin abnor-
malities (including café-au-lait macules), hepatopathy
and immunodeficiency [1–5]. All affected children, who
present with explosive diarrhoea, require parenteral nu-
trition for survival. In some instances parenteral nutri-
tion is a life-long requirement, while in others the
patient can be weaned to full enteral feeding [6]. Fine
motor movement abnormalities and mental retardation
have also been reported in some affected individuals [7].
The estimated prevalence of THE-S is approximately 1/
400,000–500,000 live births [6] and since its first
description in 1982 [1], less than 60 cases have been
described, with cases being reported from Europe, Asia,
the Middle East and North Africa.
The diagnosis should be suspected in the presence of
the clinical triad of IUGR, severe protracted diarrhoea of
early onset, and abnormal facial features with prominent
ears and cheeks [7]. Additional features are often present
but are less consistent. Even though these key syndromic
features have been very well described, the age-related
appearance of many of these features coupled with the
estimated low prevalence of this disease make it challen-
ging to recognize THE-S during early infancy [3, 7]. It
should be noted that before the hair abnormalities, liver
cirrhosis or facial dysmorphism become noticeable,
many patients fail to thrive, and suffer from intractable
diarrhoea and recurrent infections, which are three of
the 10 warning signs of primary immunodeficiency dis-
eases (PIDs) [8–11]. For these reasons, PIDs are often
initially suspected in THE-S patients. In a review of the
literature, Fabre and colleagues noted that 39 of 44 re-
ported cases presented with an immunological defect
[12]. These immunological deficits ranged from low
serum immunoglobulin levels [12], deficits in antibody
production following vaccinations [6], monoclonal hyper
IgA [13] and low lymphocyte counts [1, 3].
While our understanding of the pathogenesis of THE-
S remains limited, causal mutations in two genes,
TTC37 [6] and SKIV2L [7, 12, 14–16], both encoding
components of the human Ski complex, have been
reported. The Ski complex is an obligatory co-factor in
the RNA exosome which is crucial for the accurate pro-
cessing of nuclear RNA precursors and in the degrad-
ation of RNA in both the nucleus and the cytoplasm
[17–19] . Most reported mutations are private and are
distributed in all exons of TTC37 and SKIV2L, but a
founder mutation in TTC37 (c.2808G > A) has been re-
ported in patients from India [5].
Interestingly, one case of THE-S presenting with im-
munodeficiency without diarrhoea has recently been
reported by Rider and co-workers [15]. Their study
described a novel TTC37 mutation in a patient who pre-
sented with frequent otitis media, viral infections, puru-
lent conjunctivitis, woolly hair and distinctive facial
features without the characteristic severe diarrhoea of
infancy seen in THE-S [15].
Here we describe a patient with an atypical respiratory
presentation in which exome sequencing identified a
novel homozygous TTC37 mutation and allowed the
diagnosis of THE-S to be made.
Methods
Case description
The index patient was a male of Somalian descent, born
to consanguineous parents (first cousins once-removed,
i.e. fourth degree relatives) living in South Africa (see Fig. 1
for pedigree). He was born at 35 weeks gestation, weighing
1940 g (3rd percentile) and remained in hospital initially
for three weeks for neonatal jaundice and poor weight
gain. The parents noted subtle patchy hyperpigmentation
after he completed phototherapy for jaundice. His hair
was shaved per their custom and was reportedly not
unusual. On discharge he had received all routine vaccina-
tions including live BCG and oral Polio drops.
At age three months the patient presented with an
acute history of respiratory distress. In addition, he had
failed to thrive and his mass was 2600 g (<<3rd centile
for corrected age). There was clinical evidence of a
pneumonia and the liver edge was palpable 2 cm below
the costal margin. Patchy, poorly circumscribed areas of
hyperpigmentation were present on the trunk and limbs
(Fig. 2a). There was an exfoliating rash particularly on
the hands and feet with erythema of the palms and soles
suggestive of erythroderma (Fig. 2b). The forehead was
prominent (Fig. 2c), giving a triangular appearance to
the face, but no hypertelorism or other dysmorphic
features were noted.
An echocardiogram was performed and found to be
normal, while chest x-ray showed an extensive bilateral
interstitial pneumonitis with alveolar changes (Fig. 2d).
The C-reactive protein (CRP) increased over 3 days from
9 to 43 mg/L (ref: 0–10). Tracheal aspirate was positive
for cytomegalovirus (CMV) but not other respiratory
viruses, and CMV viraemia was documented with a viral
load of log 5.97. Blood, sputum and stool culture showed
no evidence of bacterial infection. The full blood count
was normal, with normal number of lymphocytes. On
subset analysis, the natural killer (NK) cell count was
81/microliter (ref: 300–700) and the NK cell percentage
was 3% (ref: 8–17) (Table 1). There was also a low serum
IgG levels of <1.41 g/L (ref 3.00-10.00) but normal IgA
and IgM. Liver functions showed very elevated gamma-
glutamyl transferase (942 IU/L, ref: 2–30); somewhat
elevated conjugated bilirubin (10 micromol/L, ref: 0–6),
Kinnear et al. BMC Medical Genetics  (2017) 18:26 Page 2 of 11
alanine transaminase (39 IU/L, ref: 4–35) and aspartate
transaminase (75 IU/L, ref: 0–65); low albumin (23 g/L,
ref: 28–46), and normal alkaline phosphatase (180 IU/L,
ref: 75–316). The plasma amino acid profile was normal,
as were urinary organic acids. Skin biopsy histology of a
hyperpigmented macule showed abundant melanin but
no specific features for pathological processes such as
graft versus host disease.
The patient was treated in the intensive care unit.
Treatment included ventilation with a high frequency
oscillator, intravenous ganciclovir, and other medications
as appropriate. During the admission diarrhoea was
noted, but was not a prominent feature. Following three
weeks of intensive therapy, the patient died of ongoing
severe pneumonitis. Supervening nosocomial sepsis was
suspected but unproven. The family declined an autopsy.
The clinical suspicion was of a combined immune def-
icit, with a family history that suggested an autosomal
recessive or perhaps X-linked disorder.
A male sibling born 4 years earlier, weighed 1840 g
(<<3rd centile) at term gestation. He was treated for
neonatal jaundice and subsequently readmitted at two
months of age with chronic diarrhoea, dehydration and
failure to thrive. He was noticed to have hair that was
“sticking out”, and both hyper- and hypopigmented skin
macules. Other clinical features included a prominent
forehead with a triangular face and low-set ears, penile
hypospadias and bilateral camptodactyly of the fingers.
Further laboratory investigations confirmed a secretory
diarrhoea with albumin loss and metabolic acidosis.
Endoscopic biopsies of the stomach and duodenum were
performed. The stomach histology was normal, whereas
the duodenal biopsy showed flattening and thickening of
some villi, and preserved crypt architecture; in addition
the lamina propria contained a sprinkling of lympho-
cytes and plasma cells. The liver function test was only
minimally deranged. The full blood count, lymphocyte
subsets and serum immunoglobulin profile were similar
Fig. 1 Multigeneration pedigree of the Trichohepatoenteric syndrome family
Fig. 2 Clinical features of the proband. a Hyperpigmentation of the trunk. b Exfoliating rash present at the feet of the proband. c Prominent
forehead with triangular appearance of the face. d Chest X-ray showing extensive bilateral bronchopneumonia
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to that of the index case, except that the IgA was also low.
He remained in hospital until his demise at 5 months of
age, following documented episodes of Klebsiella and En-
terococcal septicaemia. Additional investigations showed a
normal karyotype, and normal profile of urine organic
acids and urine and blood amino acids. No definitive
diagnosis was made, and some details only became avail-
able to us after the death of the index case. Phenotypic
comparisons between the index case and his deceased
brother are shown in Table 1. The couple also has a
healthy daughter, and a female stillbirth for reasons which
were considered to be unrelated (Fig. 1).
Prior to demise of the index case, the parents were
counselled on a possible genetic immunodeficiency and
consented for blood samples from all live members of
the family to be submitted for exome sequencing.
Table 1 Phenotypic comparison of both siblings to literature
Clinical feature (HPO id) Index case Affected brother Findings in 25 previously reported
cases [1, 3, 4, 6, 15]
Consanguinity Y Y 13/22 (59%)
IUGR (HP:0001511) Y Y 23/25 (92%)
Preterm <37 wk (HP:0001622) Y N 12/25 (48%)
Dysmorphism
Prominent forehead (HP:0011220) Y Y 20/20 (100%)
Hypertelorism (HP:0000316) N N 20/20 (100%)
Hypo/pigmented skin rash +/− erythroderma Y Y 6/20 (30%)
Unusual hair (Includes trichorrhexis nodosa,
HP:0009886)
Unknown (shaved) Y (‘sticking out’) 20/20 (100%)
Congenital heart defect (Abnormal heart
morphology, HP:0001627)
N N 5/20 (25%)
Musculoskelelal abnormality (Camptodactyly
HP:0005617)
N Y (camptodactyly) 1/12 (8%; Perthes disease)
Urinary tract abnormality (Hypospadias, HP:0000047) N Y (hypospadias) 3/20 (15%)
Gastrointestinal
Chronic diarrhea (HP:0002028) N Y 24/25 (96%)
Failure to thrive (HP:0001508) Y Y (needed TPN) 25/25 (100%)
Villous atrophy on biopsy of small
intestine (HP:0011473)
- Y (patchy) 21/21 (100%)
Liver dysfunction or fibrosis N N 9/17 (53%, all with liver fibrosis)
Outcome
Neurodevelopmental delay (HP:0012758) ? Y 10/16 (63%)
Death Y Y 12/25 (48%)
If deceased, age at death 3 months 5 months 2-96 months
Immunological investigations {reference range}
Lymphocyte count 2.53 {2.0–17.0 × 109/l} 4.17 {2.0–17.0 × 109/l} Where reported was normal
% B-cells (CD19) 24% {19–31%} 20% {19–31%}
% T-cells (CD3) 73% {58–67%} 72% {58–67%} Weak T-cell proliferative response in
some cases to antigens, not mitogens
% T-helper cells (CD4) 55% {38–50%} 39% {38–50%}
% T-supressor cells (CD8) 16% {18–25%} 33% {18–25%}
% Natural killer cells (CD16, 56) (Abnormality
of NK cells HP:0012176)
3% {8–17%} 8% {8–17%}
IgG level (IgG deficiency HP: 0004315) <1.41 g/l {3.0–10.0 g/l} 1.96 g/l {3.0–10.0 g/l} 11/20 (55%) had ‘low immunoglobulins’.
Other often had deficient vaccine response.
Hence THE-S now in antibody deficiency
group of the 2015 IUIS Primary
Immunodeficiency classification
IgA level (IgA deficiency HP:0002720) 0.44 g/l {0.1–0.7 g/l} <0.25 g/l {0.1–0.7 g/l}
IgM level 0.92 g/l {0.2–1.10 g/l} 1.19 g/l {0.2–1.10 g/l}
HPO id human phenotype ontology identification number, Y Yes, N No, TPN total parenteral nutrition, NK natural killer, IUGR intrauterine growth restriction, IUIS
International Union of Immunological Societies
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The study was approved by the Health Research Ethics
Committee of Stellenbosch University (study no. N13/
05/075). Parents gave informed consent to participate in
the study, which included the genetic evaluation of their
children. Additional informed consent was obtained
from the parents to include photographs in this article.
The study adhered to the ethical guidelines as set out in
the “Declaration of Helsinki, 2013” [20]. Venous blood
for DNA extraction and WES was drawn from the index
case (1 ml) and both of his parents (5 ml). Blood was
also drawn from the unaffected sister for genetic ana-
lysis. DNA was purified from blood using the Nucleon
BACC3 Kit (Amersham Biosciences, Buckinghamshire,
UK). DNA from a formalin-fixed duodenal biopsy sam-
ple of the previously deceased male sibling was extracted
using the QIAamp® DNA FFPE Tissue Kit (Qiagen,
Hilden, Germany).
Exome capture and sequencing
Library preparation for sequencing was carried out using
the Ion AmpliSeq™ Exome RDY Kit and the Ion Xpress™
Barcode Adaptors 1–16 Kit (Life Technologies, Carlsbad,
California, United States). The DNA template for se-
quencing was prepared on the Ion Chef system using
the Ion PI™ Hi-Q™ Chef Kit and the Ion PI™ Chip Kit v3.
Sequencing was carried out on the Ion Proton™ (Thermo
Fisher, Carlsbad, California, United States) at the Centre
for Proteomic and Genomic Research (CPGR), Observa-
tory, Cape Town, South Africa.
Read mapping, variant detection and functional
annotation
Sequences were aligned to the human reference gen-
ome, hg19 using Torrent Mapping Alignment Pro-
gram (TMAP, version 4.4.11-1) in the ion-analysis
workflow on the Torrent Suite (version 4.4.3). Base
quality score recalibration, indel realignment and vari-
ant calling were performed using the variantCaller
(version 4.4.3.3) plugin on the Torrent Suite and vari-
ant annotation was performed. Variant prioritization
was performed using TAPERTM, a custom-designed,
in-house method and variants in a homozygous reces-
sive state or compound heterozygous state were prior-
itized as potential candidate variants [21]. In brief,
TAPER™ 1) submits VCF files to an online variant
caller, 2) removes all synonymous and non-frameshift indel
variants, 3) removes all variants with a frequency of greater
than 1% if present in the 1000 Genomes Project or Exome
Sequencing Project 6500, 4) removes all variants with nega-
tive Genomic Evolutionary Rate Profiling (GERP) +++
scores, 5) removes all variants with Functional Analysis
through Hidden Markov Models (FATHMM) scores
greater than 0.1, 6) removes X and Y chromosome variants
(if the pedigree does not indicate sex-linked inheritance)
and lastly 7) identifies associated disorders for prioritised
genes. Additionally, to validate findings obtained using
TAPER™, variant filtering and prioritization was also done
using Ion Reporter™ Software (version 5.0).
Analysis of identity-by-descent and runs of homozygosity
Using custom scripts, the VCF files for both the mother
and father were merged to create a multi-sample VCF
file. This file was subsequently filtered for single nucleo-
tide substitutions that were flagged “PASS” by a custom
variant caller filter. Identity by descent (IBD) was calcu-
lated uing PLINK (http://zzz.bwh.harvard.edu/plink/)
[22]. IBD was estimated in order to determine the de-
gree of relatedness across the two individuals (PI(HAT)).
This is calculated by using the inferred probabilities of
individuals sharing an allele. Individuals may therefore
share no alleles, one allele or both alleles. Following IBD,
the runs of homozygosity were calculated to identify
which segments of specific chromosomes are identical to
one another. This allowed further inference of IBD as
these segments were identical as a result of inheritance
as opposed to sequence similarity.
Sanger sequencing
A 239 base pair fragment containing the candidate
variant was polymerase chain reaction (PCR)-ampli-
fied from genomic DNA of the index case, his affected
brother, his unaffected parents and his unaffected
sister using the following primers: TTC37F- 5′ AA
TCATAATCAGACACTACATCTGC-3′ and TTC37R- 5′
GCTCATAGTCATCTTTGGCATATAA. Each amplicon
was bi-directionally sequenced using the BigDye® Termin-
ator v3.1 Cycle Sequencing Kit (Perkin-Elmer, Applied
Biosystems Inc., Foster City, California, USA.), followed by
electrophoresis on an ABI 3130XL Genetic Analyzer
(Perkin-Elmer, Applied Biosystems Inc., Foster City,
California, USA). All automated DNA sequencing reac-
tions were performed at the Central Analytical Facility at
Stellenbosch University, Stellenbosch, RSA.
Results
IBD and segmental sharing were calculated between the
two parents of the index case. A PI(HAT) score of
0.082765 (Table 2) was calculated for the parents of the
proband. This is within the range of what would be ex-
pected for first degree cousins. Moreover, eight runs of
Table 2 Identity by descent scores (IBD) between the mother
and father of the index case
FID1 IID1 FID2 IID2 Z0 Z1 Z2 PI(HAT)
PID027 Mother PID027 Father 0.05379 0.04621 0.07311 0.082765
FID Family ID, IID Individual ID, Z0 probability that individuals at a specific
marker will share no alleles, Z1 probability that individuals at a specific marker
will share 1 allele, Z2 probability that individuals at a specific marker will share
2 alleles
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homozygosity across six chromosomes were identified in
the proband (Table 3).
The summary of the exome sequencing data for the
index case and both his parents are presented in Table 4.
Following filtering for rare or unreported variants a total
of seven rare, homozygous variants were identified
(Table 5). Following further analysis and database mining
for gene-disease association, we identified a rare, low fre-
quency homozygous missense mutation c. 4507C > T
(rs200067423) in exon 42 of TTC37 (NM_014639) which
results in the substitution of an arginine with a cysteine at
amino acid 1503 (p.R1503C) as a possible disease-causing
variant. This is the first time that this variant has been
identified in homozygous form and the read depth of this
variant was 43X. This variant was found in one of the
eight identified runs of homozygosity (Table 3). Addition-
ally, using the American College of Medical Genetics this
variant is classified as likely pathogenic pathogenic
(One moderate and four supporting; PM2, PP1, PP2,
PP3 and PP4) [23]. No other known disease-causing
mutations were identified in TTC37 or SKIV2L, both of
which were 100% covered by WES. Additionally, no
disease-causing mutation was identified on the X
chromosome (Additional file 1: Tables S1 and S2).
The presence of the variant in the patient and fam-
ily members was verified using Sanger sequencing.
The details of the mutation are summarised in
Table 6. In silico predictions of the pathogenicity of
the TTC37 c. 4507C > T mutation (SIFT, Polyphen)
found that this mutation is damaging (Table 5). Mul-
tiple sequence alignment between species showed that
the mutation occurs at a highly conserved residue
(Fig. 3). Both parents as well as the healthy sister
were heterozygous for the mutation, while the previ-
ously deceased sibling was homozygous (Fig. 4). This
is the first reported case of THE-S in a patient of So-
mali descent as well as the first reported case in
South Africa.
Discussion
THE-S is an extremely rare autosomal recessive dis-
order that typically manifests with severe, explosive
diarrhoea in infancy, hair abnormalities, dysmorphic
facial features and immunodeficiency. Here we describe
brothers with a rare homozygous TTC37 mutation (not
previously described in the homozygous state), and
presenting with many THE-S clinical features, but an
atypical presentation in the index case. Due to this
atypical presentation, and the lack of some of the spe-
cific features, THE-S was not initially considered. The
characteristic hair abnormalities were not observed
because his head was shaven. In addition, THE-S has
not been previously diagnosed in South Africa, where
consanguinity is uncommon.
The sibling of the index case had a more typical gastro-
intestinal presentation for THE-S, but the details of the
case were not immediately available. In addition, the pres-
ence of hypospadias and camptodactyly would suggest
consideration of other diagnostic possibilities. As a result,
although a Mendelian disorder, either autosomal recessive
or X-linked, was strongly suspected, the differential diag-
nosis remained broad despite quite extensive laboratory
investigation.
Table 3 The identification of runs of homozygosity between the mother and father of the index case
CHR SNP1 SNP2 POS1 POS2 KB NSNP DENSITY (KB/NSNP) PHOM PHET
1 rs6077208 rs773530539 21798208 23743698 1945.49 116 16.771 0.603 0.017
2 rs558321757 rs23253874 25050977 33764286 8713.30 236 36.920 0.674 0.038
2 rs773745425 rs83697568 178415694 180846743 2431.04 123 19.764 0.789 0.008
5 rs107007917 rs70038334 90719129 94953379 4234.25 151 28.041 0.314 0.508
6 rs7451498 rs9384046 148981394 153173999 4192.60 163 25.721 0.662 0.131
14 rs10134181 rs898927 92280037 98263147 5983.11 244 24.520 0.297 0.637
16 rs4785195 rs1004299 49932806 54343840 4411.03 129 34.194 0.676 0.180
16 rs990813 rs12596363 59070616 64124789 5054.17 117 43.198 0.088 0.124
Bold font denotes ROH in which TTC37 is localized. All calculations were done using the VCF file obtained for the WES. Stringent quality control parameters were
implemented before identity by decent (IBD) and ROH were calculated. Note that because of missing calls, PHOM + PHET < 1
SNP1 start of the SNP segment, SNP2 end of the SNP segment, POS1 start of the physical position of the segment (base pair), POS2 end of the physical position of
the segment (base pair), NSNP number of SNPs in the segment, KB physical length of the segment, PHOM proportion of sites homozygous, PHET proportion of
sites heterozygous
Table 4 Summary of exome sequencing data for the index case
and his parents
Proband Mother Father
Total captured regions size 64 Mb 64 Mb 64 Mb
% of captured regions with coverage >10 99.7 99.7 99.8
Average coverage of captured region (%) 98.8 98.6 99.0
Total number of SNPs 21,858 22,433 22,043
Total number of INDELs 510 503 515
N rare homozygous 23 11 16
N rare heterozygous 269 201 201
N X linked 21 15 18
SNP single nucleotide polymorphism
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Whole exome sequencing, conducted to clarify the
clinical diagnosis, revealed a rare homozygous missense
c. 4507C > T mutation (rs200067423) in TTC37, one of
two genes previously implicated in THE-S in several in-
dependent investigations. The patient was found to be
homozygous for the mutation while each of his consan-
guineous parents and his unaffected sister were he-
terozygous. We also identified the same homozygous
mutation in his affected brother. This mutation results
in a substitution of an arginine, which is a hydrophilic
positively charged amino acid, with a hydrophobic
uncharged cysteine residue at amino acid position 1503
of the protein. Based on the differences in charge and
hydrophobicity between the arginine and cysteine and
the fact that cysteine has the potential to form di-
sulphide bonds, it is highly likely that the mutation leads
to the loss of hydrogen bonds or impairs the proper
folding of TTC37 [24]. Additionally, multiple species
alignment shows that the mutation occurs at a highly
conserved residue.
The findings on history, examination and laboratory
investigations in both affected boys are consistent
with a diagnosis of THE-S, despite the atypical pres-
entation in the index case. IUGR is described as a
consistent finding [7] and was present in both af-
fected boys. The pre-deceased brother had chronic
secretory diarrhoea with onset in early infancy, with
associated failure to thrive, as described in the ori-
ginal article by Stankler et al.[1]. In the index case
diarrhoea was present but less prominent than the
severe respiratory infection.
On examination, a wide and prominent forehead is a
consistent finding in THE-S [6] and was present in both
cases. Skin changes occur frequently and include ery-
throderma [3] and patchy skin hyperpigmentation [7].
The index case had erythroderma and both had patchy
hyperpigmentation. Trichorrhexis nodosa was not for-
mally assessed, but the earlier sibling was known to have
unusual-looking scalp hair. Both had neonatal jaundice
and the index case had evidence of ongoing liver
dysfunction, which is a common finding in THE-S [6].
The findings on duodenal histology for the earlier sibling
were not very specific, but were consistent with previ-
ously reported findings in THE-S. Taken together, the
results of the exome sequencing in the index case and
the clinical findings in both affected siblings confirm a
diagnosis of THE-S.
The fulminant CMV pneumonitis in the index case,
taken together with the abnormal immunological pro-
file, suggests underlying primary immunodeficiency.
While humoral immune deficits are known to be com-
mon in THE-S [6, 14], the low natural killer (NK) cell
count, more marked in the index case, has not been
previously described. NK cells are important in recog-
nizing and killing virally infected cells, and deficiency
predisposes specifically to severe infections with herpes
viruses such as CMV [25]. This provides a possible
Table 6 Details of the candidate variant narrowed down using
consecutive filters based on an autosomal recessive model of
inheritance and low frequency
Chromosome Chr 5
Position 94803683
Gene name TTC37
RefSeq NM_014639
Reference sequence G
Proband: number of reads with reference 0
Proband: alternative A
Proband: number of reads with alternative 43
Mother: number of reads with reference 88
Mother: alternative A
Mother: number of reads with alternative 43
Father: number of reads with reference 49
Father: alternative A
Father: number of reads with alternative 11
Mutation type Missense
Mutation: DNA (HGVS nomenclature _c.) c.4597 C > T
Mutation: protein (HGVS nomenclature _p.) R1503C
Prediction < SIFT Damaging
Prediction < PolyPhen-2 Probably damaging
Sanger verification Yes
HGVS Human Genome Variation Society, SIFT Sorting Intolerant from Tolerant
Fig. 3 ClustalW multiple sequence alignment showing the highly conserved position of the c.4507C > T (p.1053R > C) mutation in TTC37
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explanation for the severity of the CMV pneumonitis.
Although childhood exposure to CMV is common, we
found two prior cases of CMV hepatitis in previous re-
ports of THE-S [3, 4], one of which occurred shortly
after liver transplantation and therefore perhaps was
secondary to use of immunosuppressants [4]. The pre-
disposition to severe CMV may not be common in
THE-S, but an alternative possibility is that THE-S is
undetected in cases with early death.
Conclusions
WES has been available for several years, but its useful-
ness as a routine clinical diagnostic tool is only now be-
ginning to emerge [26, 27]. WES has particular value in
diagnosing the cause of rare conditions with unclear
phenotypes [28] or with an atypical presentation [29] as
found in our index case. We demonstrate how WES,
together with detailed phenotyping of a previously and
more typically affected family member, led to a post-
mortem molecular diagnosis of THE-S in an atypical
index case. This allowed for genetic counselling and po-
tential further genetic testing in the family; for carrier
status, diagnosis or prenatal diagnosis. The findings in
the index case broaden the range of phenotypes associ-
ated with THE-S to include presentation with fulminant
CMV pneumonitis, and low NK cell count. We recom-
mend that immunological investigations for known or
suspected cases of THE-S include detailed immune
function testing of antibody related function, but also
careful screening for viral infections [10].
Fig. 4 Validation of the mutation using Sanger sequencing. The proband (indicated by the black arrow) and affected deceased brother are
homozygous for TTC37 c.4507C > T (p.1503R > C), while both unaffected parents as well as the unaffected sibling are heterozygotes
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